Structure Therapeutics Inc.
GPCR
$32.12
-$2.45-7.09%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -5.99% | 17.09% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.74% | 25.11% | |||
| Operating Income | -4.74% | -25.11% | |||
| Income Before Tax | -6.64% | -31.64% | |||
| Income Tax Expenses | -22.30% | 41.84% | |||
| Earnings from Continuing Operations | -6.57% | -31.66% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -6.57% | -31.66% | |||
| EBIT | -4.74% | -25.11% | |||
| EBITDA | -4.63% | -25.20% | |||
| EPS Basic | -4.85% | -31.21% | |||
| Normalized Basic EPS | -4.92% | -31.18% | |||
| EPS Diluted | -4.85% | -31.21% | |||
| Normalized Diluted EPS | -4.92% | -31.18% | |||
| Average Basic Shares Outstanding | 1.63% | 0.35% | |||
| Average Diluted Shares Outstanding | 1.63% | 0.35% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||